TheMjPro a Project of Reinforcelab

by Reinforce Lab | Nov 16, 2016

Reinforce Lab

Crizonix a Project of Reinforcelab

by Reinforce Lab | Jul 23, 2016

Crizonix – A Project of Reinforcelab

Crizonix is the global first generic preparation of Crizotinib. CRIZONIX is indicated as the first-line treatment of adults with ALK-positive advanced Non Small Cell Lung Cancer(NSCLC) and ROS1 (+) NSCLC. Crizotinib is an ALK and ROS1 (c-ros oncogene 1, receptor tyrosine kinase) inhibitor. This Crizonix is 13 times affordable than originator and the quality of the product is to that of International Standard GMP compliant. Beacon Pharmaceuticals Limited manufactured this product in a dedicated oncology facility. They are providing worldwide delivery support.

During this project we have completely changed the layout and place the menu in the side bar. At the same time, we have ensured best quality design for the website to make it user friendly for the customers. Also, set several call action to increase the sales rate of the product’s website.

Project Details

Client: Beacon Pharmaceuticals Limited
Date: 10.08.2016
Skills: Branding, Web Design, Oncology Product’s Website
View: http://www.crizonix.com

Like What You See?

Get In Touch

Reinforce Lab

Sofosvel a Project of Reinforcelab

by Reinforce Lab | Jul 23, 2016

Sofosvel – A Project of Reinforcelab

Project Description

Sofosvel is the global first generic oral tablet for pan-genotypic Chronic Hepatitis C treatment manufactured by Beacon Pharmaceuticals Limited. This combination (Sofosbuvir 400 mg + Valpatasvir 100 mg) drug has been approved by US FDA & European Commission for treatment of patients with all genotypic Chronic Hepatitis C virus infection. Sofosvel is used without cirrhosis or with compensated cirrhosis, and patients with advanced cirrhosis (Decompensated).

We have ensured best quality design for the website to make it user friendly for the customers. We have also set several call action to increase the sales rate of the product’s website.

Project Details

Client: Beacon Pharmaceuticals Limited
Date: 27.07.2016
Skills: Branding, Web Design, Hepatitis C Product’s Website
View: http://www.sofosvel.com

Like What You See?

Get In Touch

Reinforce Lab

Unix Jutex Ecommerce Website

by Reinforce Lab | Jul 3, 2016

About The Unix Jutex E-Commerce Project

Reinforce Lab is very happy to work with Unix Enterprise to build their Unix Jutex ecommerce shop. They have very unique custom-made designs which are very attractive. The people in this company are very friendly to work and very helpful indeed.

Reinforce lab used logo color of the company to build the website. At the same time, we have maintained modern and high quality ecommerce shops standard to comply with current ecommerce industry looks.

Unix Jutex is one of the leading jute products manufacturer and exporter of high quality eco-friendly bio-degradable jute products around the world.

Unix Enterprise has started its journey on 2014 with a vision of green world.

To come back the golden fiber of Bangladesh from the brink, they are committed to produce good quality jute and burlap handicraft products to meet the demand of consumers as Theyll as to keep the world green.

Their mission is to raise the global awareness for preventing the adverse impact of synthetic products in the world.

With growing environmental awareness, jute, which is biodegradable, has become the preferred alternative to polluting synthetic bags and plastics.

We have ensured best quality design for the website to make it user friendly for the customers. We have also set several call action to increase the sales rate of the shop. We also tried to make the full quality shop with an affordable price.

Tools & Skills:

Technical Language: PHP

Theme: Divi Multipurpose Theme

Pugins: Divi Builder

WordPress Version: 4.5.2

Reinforce Lab

Tagrix a Project of Reinforcelab

by Reinforce Lab | Jun 22, 2016

Tagrix – A Project of Reinforcelab

Project Description

Tagrix (Osimertinib) is a product website which is a blockbuster product of Beacon Pharmaceuticals Limited. the first of its kind to be indicated for patients with T790M mutation-positive NSCLC, irrespective of previous treatment with an EGFR tyrosine kinase inhibitor (TKI). Tagrix (Osimertinib) targets both the EGFR mutation that triggers cancer development and T790M. Tagrix is the first global generic preparation of Tagrix (Osimertinib) which is approved by Directorate of Drug Administration, Ministry of Health and Family Welfare, People’s Republic of Bangladesh.

Project Feature

We have ensured best quality design for the Tagrix website to make it user friendly for the customers . We have also set call action to increase the sales rate of the product. We also tried to make the full quality product’s website with an affordable price.

Live Project